Tag: Rare disease treatments partnership
Advancing RNA-Based Drugs in Rare Diseases: Sarepta and Arrowhead Pharmaceuticals Partnership
Sarepta Therapeutics has announced a significant partnership with Arrowhead Pharmaceuticals to develop RNA-based drugs for rare diseases. The deal includes a $500 million cash payment from Sarepta to Arrowhead, along with a $325 million...